About this episode

This episode discusses the approval of semaglutide as the first oral GLP-1 agonist for weight loss and its implications for treatment.

A new oral option is changing the GLP-1 landscape for weight loss, along with raising questions about efficacy, dosing, and when switching products makes sense. In this episode, TRC Healthcare Associate Editor and Clinical Pharmacist Vickie Danaher, PharmD discusses how semaglutide became the first FDA-approved oral GLP-1 agonist for obesity. She breaks down how it works, how it compares to injectable options, and dosing considerations for patients. Vickie also walks through key counseling po...

People in this episode

Host: Vickie Danaher

Topics covered

• GLP-1
• weight loss
• semaglutide
• oral medication
• dosing considerations
• counseling

Keywords

• semaglutide
• oral GLP-1
• weight loss
• dosing
• efficacy
• counseling

Mentioned in this episode

Organizations: FDA, TRC Healthcare

Products: semaglutide

More episodes of Clinical Capsules - Actionable Medication Pearls in Minutes

• Updated COPD Guidelines: Strategies for Treatment and Management · May 26, 2026 · 19 min
• Beyond the Cuff: Measuring and Monitoring Blood Pressure · May 12, 2026 · 16 min
• Managing Opioid Overdose: Signs, Symptoms, and Reversal Agents · March 24, 2026 · 18 min
• Treating Dry Eye Disease: A Look at Today’s Medications · March 10, 2026 · 15 min
• First-Time Rx Oral Liquids for Common Meds · February 24, 2026 · 17 min
• Hypothyroidism Meds: Answers to Common Questions · February 10, 2026 · 15 min

Explore listener stats, chart rankings, contacts and more on the Clinical Capsules - Actionable Medication Pearls in Minutes podcast page.